Premium
The Hydroxypyridinone Iron Chelator CP94 Can Enhance PpIX‐induced PDT of Cultured Human Glioma Cells
Author(s) -
Blake Emma,
Curnow Alison
Publication year - 2010
Publication title -
photochemistry and photobiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.818
H-Index - 131
eISSN - 1751-1097
pISSN - 0031-8655
DOI - 10.1111/j.1751-1097.2010.00770.x
Subject(s) - photodynamic therapy , photosensitizer , protoporphyrin ix , glioma , chemistry , prodrug , in vitro , cytotoxicity , chelation , cancer research , fluorescence , biochemistry , pharmacology , photochemistry , biology , organic chemistry , physics , quantum mechanics
Photodynamic therapy (PDT) with the pro‐drugs 5‐aminolevulinic acid (ALA) or methyl aminolevulinate (MAL) utilizes the combined interaction of a photosensitizer, light and molecular oxygen to ablate tumor tissue. To potentially increase accumulation of the photosensitizer, protoporphyrin IX (PpIX), within tumor cells an iron chelator can be employed. This study analyzed the effects of ALA/MAL‐induced PDT combined with the iron chelator 1, 2‐diethyl‐3‐hydroxypyridin‐4‐one hydrochloride (CP94) on the accumulation of PpIX in human glioma cells in vitro . Cells were incubated for 0, 3 and 6 h with various concentrations of ALA/MAL with or without CP94 and the resulting accumulations of PpIX, which naturally fluoresces, were quantified prior to and following light irradiation. In addition, counts of viable cells were recorded. The use of CP94 in combination with ALA/MAL produced significant enhancements of PpIX fluorescence in human glioma cells. At the highest concentrations of each prodrug, CP94 enhanced PpIX fluorescence significantly at 3 h for ALA and by more than 50% at 6 h for MAL. Cells subsequently treated with ALA/MAL‐induced PDT in combination with CP94 produced the greatest cytotoxicity. It is therefore concluded that with further study CP94 may be a useful adjuvant to photodiagnosis and/or PpIX‐induced PDT treatment of glioma.